<DOC>
	<DOC>NCT00277472</DOC>
	<brief_summary>This study will assess the efficacy and safety of valsartan/hydrochlorothiazide combination therapy in patients with hypertension not controlled with hydrochlorothiazide monotherapy.</brief_summary>
	<brief_title>Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Male or female 18 years of age and older Diagnosed as having hypertension (mean seated systolic blood pressure ≥ 150 mm Hg but &lt; 180 mm Hg and mean seated diastolic blood pressure ≥ 95 mm Hg and &lt;110 mm Hg Patients with sever hypertension: Systolic ≥ 180 mm Hg or Diastolic ≥ 110 mm Hg Diabetes with fasting glucose &gt; 126 mg/dl or on existing antidiabetic medication History of stroke, transient ischemic attack, or myocardial infarction within the last 6 months, or diagnosed with congestive heart failure. Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>High blood pressure</keyword>
	<keyword>diuretics</keyword>
	<keyword>valsartan</keyword>
</DOC>